天臣医疗: directors' dealings · France · AMF SSE:688013 FR FR · AMF Mcap 3.9Bn€
Explore the full insider trade history of 天臣医疗, a publicly traded company based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €3.9bn. The latest transaction was reported on 27 January 2026 — Sale. Among the most active insiders: 丁水澄. The full history is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 326.7 M€
Gross profit 208.9 M€ 64% margin
Net income 85.2 M€ 26.1% margin
Balance sheet & cash
Market cap 3.90 Bn€
Total debt 50.5 M€
Free Cash Flow −18.8 M€
Last declaration on 27 January 2026
Declarations 11 total
Executives ● Sale2 SSE
10,000 shares
SSE:273000000154506720 · 27 Jan 2026
Executives ● Purchase7 SSE
16,000 shares
SSE:173000008516010780 · 27 Jan 2025
Ideal exit: 24 Oct 2025 (T+270) Executives ● Sale2 SSE
29,004 shares
SSE:173000008214155360 · 1 Nov 2024
Executives ● Sale2 SSE
2,000 shares
SSE:173000006887283900 · 31 Aug 2023
Executives ● Sale2 SSE
16,000 shares
SSE:173000006636984700 · 5 Jun 2023
Executives ● Sale2 SSE
2,000 shares
SSE:173000006628061540 · 31 May 2023
Executives ● Sale2 SSE
14,000 shares
SSE:173000006614201800 · 24 May 2023
Executives ● Sale2 SSE
7,000 shares
SSE:173000006564492400 · 4 May 2023
Executives ● Sale7 SSE
497,600 shares
SSE:173000005908510430 · 26 Sept 2022
Executives ● Sale7 SSE
475,400 shares
SSE:173000005118839360 · 29 Nov 2021
Executives ● Sale7 SSE
699,400 shares
SSE:173000005109814620 · 26 Nov 2021